RetinaLyze International

RetinaLyze International Safe, fast and efficient retinal investigations with RetinaLyze AI and Telemedicine.

A patient came in with a simple story.He had bent down to pick something up… and suddenly his vision in one eye became b...
01/04/2026

A patient came in with a simple story.

He had bent down to pick something up… and suddenly his vision in one eye became blurred.
Not gone, just off.

Over the next hours, it started to improve, but something still wasn’t right. He described it as grey shadows above and below, while straight ahead seemed clear.

Visual acuity was still 0.8 as the last visit.
It would be easy to downplay.

But when we compared retinal images from a few months earlier, the picture changed. The newer image showed signs consistent with a branch retinal artery occlusion (BRAO).

This is where it gets tricky!

A branch retinal artery occlusion doesn’t always present dramatically. Because only part of the retina is affected, patients can keep relatively good central vision. Instead, they notice subtle field defects, shadows, missing areas, something “not quite right.”

If symptoms improve, there's even more reason it can be overlooked.

On fundus images, you may see a sector of the retina that looks pale or washed out, following the distribution of the affected artery. Sometimes it’s obvious. Sometimes it’s easy to miss. Especially without something to compare it to.

The combination of patient story + imaging + comparison over time is what reveals the real diagnosis.

Cases like this are a good reminder:
Not every serious retinal event comes with poor visual acuity or dramatic symptoms. And not every “improvement” means resolution.

AI decision support: Raising clinical confidence while saving time - RetinaLyze x As part of our cooperation with Medibr...
30/03/2026

AI decision support: Raising clinical confidence while saving time - RetinaLyze x

As part of our cooperation with Medibrix, their AI Decision Support brick brings advanced, certified tools directly into the daily routines of optical stores, clinics, and ophthalmology teams.

🔹 Fast, reliable and certified assessments
Fundus photos and OCTs can be analyzed instantly, helping clinicians detect early signs of diabetic retinopathy, AMD, glaucoma, and other retinal conditions.

🔹 An opportunity to expand services
With AI safety nets in place, optometrists can confidently broaden their menu of clinical offerings adding more value for customers and patients.

🔹 A powerful training companion
AI becomes a second set of eyes that helps new clinicians build skills, spot subtle findings, and grow faster in their clinical journey.

Bringing these AI into the Medibrix ecosystem means eye care teams can deliver safer, smarter, and more standardized care without slowing down the workflow.

Optometry can’t stand still.Demand for eye care is rising. Complexity is increasing.And yet, too often, the system still...
25/03/2026

Optometry can’t stand still.

Demand for eye care is rising. Complexity is increasing.
And yet, too often, the system still works in silos.

On World Optometry Day 2026, the message from the World Council Of Optometry is clear:

Collaboration is no longer optional!

Optometrists are more than refractionists. They are the front line of detection.
The gatekeepers of early intervention.

And a critical link to ophthalmology and wider healthcare.

At RetinaLyze System A/S, we build for that reality with AI that fits into real workflows, tools that strengthen clinical decision-making and technology that connects, rather than isolates.

Thank you to all the optometrists working with us to improve eye care around the world!

World Optometry Day is a chance to celebrate the people moving eye care forward! Not only through patient care, but thro...
23/03/2026

World Optometry Day is a chance to celebrate the people moving eye care forward!

Not only through patient care, but through collaboration, education, and research.

This year’s World Optometry Week theme from the World Council Of Optometry is “A Shared Vision: Collaboration in Global Eye Care”, celebrated March 22–28, 2026, with World Optometry Day on March 23.

One optometrist who reflects that spirit well is Sarah Farrant. She has built a strong reputation as an expert in therapeutics and dry eye management, has served as President of the BRITISH CONTACT LENS ASSOCIATION LIMITED, spent 12 years on the College of Optometrists council, chaired the Somerset Local Optical Committee, and has been described as instrumental in initiatives that improve both professional education and patient access to eye care.

She also continues to champion academic excellence, curiosity, and responsible use of new technologies in practice.

At RetinaLyze System A/S, we believe progress in eye care happens faster when knowledge is shared and technology helps connect professionals across settings.

Our work is built around supporting collaboration between optometrists, ophthalmologists, clinics, and healthcare systems.

We help make retinal screening more accessible, scalable, and actionable.

Because better outcomes start with a shared vision.

Thank you to all optometrists, researchers, educators, and clinical partners who keep pushing the profession forward.

What a day at Sociedad Española de Retina y Vítreo in Madrid!If you haven't already, be sure to visit Bloss Group who wi...
20/03/2026

What a day at Sociedad Española de Retina y Vítreo in Madrid!

If you haven't already, be sure to visit Bloss Group who will be showcasing RetinaLyze System A/S tomorrow!

AI-powered retinal screening with a special focus on glaucoma progression monitoring.

Stand 8–9

Going to Sociedad Española de Retina y Vítreo at the Madrid Marriott Auditorium Hotel & Conference Center?Be sure to vis...
19/03/2026

Going to Sociedad Española de Retina y Vítreo at the Madrid Marriott Auditorium Hotel & Conference Center?

Be sure to visit Bloss Group who will be showcasing RetinaLyze!

AI-powered retinal screening with a special focus on glaucoma progression monitoring!

Learn how our technology helps clinicians detect changes earlier, track disease development over time, and support more precise decision-making in daily practice.

👁️ See you at the 29th SERV Congress in Madrid!
📆 March 20–21 | 📍 Madrid Marriott Auditorium | Stand 8–9

17/03/2026

It’s been a full day on the road for Teddy and Ganesh from RetinaLyze System A/S.

We've been meeting partners, exploring new markets, and having great conversations about the future of eye screening.

One thing is clear:
The demand for smarter, scalable screening solutions is growing fast.

So what does a RetinaLyze partnership actually offer?
• More value from existing devices

Turn every fundus camera into a stronger revenue driver with AI-powered screening workflows.

• Access to new customer segments
Reach opticians, pharmacies, GPs, and telemedicine providers who are entering eye care.

• Stronger device sales
Make your offering more attractive by bundling imaging hardware with AI-driven diagnostics.

• Recurring revenue streams
Move beyond one-time sales with usage-based income tied to every screening performed.

In short:
We help you sell more, reach further, and build long-term value.
We’re actively looking for distribution partners ready to grow with us.

Interested?
Let’s talk → info@retinalyze.com

Can a 2D fundus image reveal the third dimension?At opti 2026 in Munich, we introduced our new glaucoma AI algorithm fro...
16/03/2026

Can a 2D fundus image reveal the third dimension?

At opti 2026 in Munich, we introduced our new glaucoma AI algorithm from RetinaLyze International. The response sparked an idea: this needs a proper online demonstration.

Now it’s happening.

Together with the partnerauge GmbH, and eyebizz, RetinaLyze DACH is hosting a free live webinar on March 17 at 10:00 titled:

“Zukunft der Augengesundheitsversorgung in die richtigen Bahnen lenken”

During the session we will demonstrate how 3D information can be derived from standard 2D fundus images and what this could mean for glaucoma screening and early detection in optometric practice.

We will also briefly share some of the other solutions and updates presented at opti 2026.

Another highlight:
Svenja Dominique Kim, who recently joined the RetinaLyze team, will take part in a short interview about a topic many in the industry are discussing:

Why optometrists and optical stores are - and should remain - the first point of contact in eye health screening.

If you work in optometry, ophthalmology, or eye care technology, this session will give a practical look at where screening tools are heading.

Register here (free):
https://us02web.zoom.us/webinar/register/5317732301510/WN_7DSMoPWmTGmYKL3xZQASgg #/registration

Glaucoma is called the “silent thief of sight.”But there is nothing silent about the people working every day to stop it...
11/03/2026

Glaucoma is called the “silent thief of sight.”

But there is nothing silent about the people working every day to stop it.

During World Glaucoma Week, we want to recognize the clinicians, researchers, and innovators pushing glaucoma care forward.

Across the world, ophthalmologists and optometrists are asking the hard questions:

• How can we detect glaucoma earlier?
• How can we identify progression sooner?
• How can technology support better clinical decisions?

One of the people helping move ophthalmology into a new era is Pearse A. Keane.

As Professor of Artificial Medical Intelligence at UCL Institute of Ophthalmology and consultant ophthalmologist at Moorfields Eye Hospital NHS Foundation Trust, he has been at the forefront of applying AI to ophthalmic imaging.

His work has helped demonstrate how deep learning can analyze retinal images at scale and assist clinicians in detecting eye disease earlier.

That shift toward data-driven ophthalmology is transforming the field.

And it matters enormously for diseases like glaucoma, where early detection is everything.

But progress in glaucoma care is never the work of one person.

It is the collective effort of a global community:

World Glaucoma Association (WGA)
ARVO – Association for Research in Vision and Ophthalmology
European Glaucoma Society
American Academy of Ophthalmology
International Council of Ophthalmology

… and thousands of dedicated clinicians and researchers worldwide.

At RetinaLyze, we are proud to contribute to this mission.

Our AI-based retinal analysis technology helps eye care professionals detect early signs of disease from fundus images, supporting screening programs and expanding access to eye care.

Because whether we work in clinics, universities, or technology the goal is the same.

Detect earlier.
Treat sooner.
Protect vision.

Last chance to visit Jessica de Groot and Lynn Albersen from ROCKMED Vision at Nederlands Contactlens Congres (NCC).They...
09/03/2026

Last chance to visit Jessica de Groot and Lynn Albersen from ROCKMED Vision at Nederlands Contactlens Congres (NCC).

They're showcasing RetinaLyze Glaucoma with 3D visualizations!

A next-generation imaging tool that helps clinicians better see, understand and communicate structural changes in glaucoma cases. Clearer visualization means more confident diagnosis, stronger patient communication and better informed treatment decisions.

Be sure to visit Rockmed Vision at Booth 21 or EyeVinci B.V. at Booth C2.

The future of eye care in Germany – are we steering it in the right direction?Our German distributor RetinaLyze DACH  is...
02/03/2026

The future of eye care in Germany – are we steering it in the right direction?

Our German distributor RetinaLyze DACH is hosting a webinar that goes straight to the heart of where optometry and ophthalmology are heading.

The title is:
“Zukunft der Augengesundheitsversorgung in die richtigen Bahnen lenken”
(Shaping the future of eye health in the right direction.)

• How screening can be implemented in daily practice without disrupting workflow
• How optometrists can take a stronger role in early detection
• How collaboration between optometry and ophthalmology can reduce pressure on clinics
• How AI-based tools such as RetinaLyze System A/S can support clinical decisions without replacing them

Primary eye care is changing. The demand for early detection of retinal disease is growing. At the same time, access to ophthalmology is strained in many regions. That gap creates both responsibility and opportunity.

If you are working in optometry, ophthalmology, or distributing diagnostic equipment in Germany, this webinar is worth your time.

Read more and sign up right here for a free webinar with Svenja Dominique Kim, Ingo Rütten, Barbara Anthonsen and Michael Anthonsen: https://www.augenscreening.eu/zukunft-der-augengesundheitsversorgung-in-die-richtigen-bahnen-lenken

Transforming the patient journey with smarter questionnaires - RetinaLyze x MedibrixOne of the most underrated workflow ...
25/02/2026

Transforming the patient journey with smarter questionnaires - RetinaLyze x Medibrix

One of the most underrated workflow upgrades in eye care is letting customers share the right information before they arrive.

As part of our cooperation with Medibrix, we’re excited about how their customizable pre- and post-visit questionnaires help optical stores, clinics, and ophthalmology departments work more efficiently while improving clinical quality at the same time.

Here’s what their questionnaire “brick” makes possible:
🔹 Collect health and lifestyle data before appointments
Patients arrive better prepared and clinicians get a head start.

🔹 Turn customer data into prewritten preliminary notes
Less typing, fewer manual steps, and more time focused on the actual eye exam.

🔹 Gather specific consents
Whether it’s for treatments, telemedicine services, or marketing outreach, consents are structured and stored properly.

🔹 Route customers into the right workflow
From diabetic screenings to children’s exams to dry-eye assessments, the system adapts automatically.

🔹 Provide tailored pre-visit feedback
Customers receive the relevant guidance before stepping into the store or clinic.

Together with Medibrix, we’re supporting eye care teams in creating smarter, more consistent workflows, while keeping the customer experience front and centre.

Adresse

Lyskær 1
Skovlunde
2730

Hvad er åbningstiderne?

Mandag 09:00 - 17:30
Tirsdag 09:00 - 17:30
Onsdag 09:00 - 17:30
Torsdag 09:00 - 17:30
Fredag 09:00 - 17:30

Internet side

Underretninger

Vær den første til at vide, og lad os sende dig en email, når RetinaLyze International sender nyheder og tilbud. Din e-mail-adresse vil ikke blive brugt til andre formål, og du kan til enhver tid afmelde dig.

Kontakt Praksis

Send en besked til RetinaLyze International:

Del

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Prevention of blindness through AI

RetinaLyze prevents loss of eyesight by making eye screening accessible. 80% of all blindness is preventable. Early screening and diagnosis is crucial and possible with Retinalyze'​ automated retinal screening tools and telemedicine solutions. Our mission is to make it easier for people all over the world to have their eyes tested and prevent the tragic consequences caused by late treatment of retinal lesions.

RetinaLyze® is a screening software, which helps eye care professionals perform screenings for eye diseases in a safe and efficient manner. The automated algorithm (AI) module detects eye diseases by analyzing fundus images. It can be used as a clinical decision support system (CDSS) or as a screening tool in conjunction with the telemedicine module. Retinalyze System A/S is a registered company in Denmark. Check us out at https://RetinaLyze.com.